用于治疗黄斑变性的药物组合物（WO2012079419）。
Pharmaceutical composition for treating macular degeneration (WO2012079419).
机构信息
Tulane University, Department of Cell and Molecular Biology, LA, USA.
出版信息
Expert Opin Ther Pat. 2013 Feb;23(2):269-72. doi: 10.1517/13543776.2013.751972. Epub 2012 Dec 10.
Abstract
A pharmaceutical composition composed of several traditional Chinese medicines is claimed to treat age-related macular degeneration (AMD). This represents a novel and alternative therapeutic solution for wet AMD, with the potential advantage of treating both the symptoms and the underlying causes of this devastating degenerative retinal disease.
摘要
据称，一种由几种中药组成的药物组合物可用于治疗年龄相关性黄斑变性（AMD）。这为湿性 AMD 提供了一种新颖且可供选择的治疗方案，具有治疗这种破坏性退行性视网膜疾病的症状和根本原因的潜在优势。
相似文献
1
Pharmaceutical composition for treating macular degeneration (WO2012079419).用于治疗黄斑变性的药物组合物（WO2012079419）。
Expert Opin Ther Pat. 2013 Feb;23(2):269-72. doi: 10.1517/13543776.2013.751972. Epub 2012 Dec 10.
2
Pegaptanib for neovascular age-related macular degeneration.培加替尼用于治疗新生血管性年龄相关性黄斑变性。
Issues Emerg Health Technol. 2005 Dec(76):1-4.
3
Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration.年龄相关性黄斑变性脉络膜新生血管中bevacizumab 治疗相关的解剖学改变与视觉功能临床指标的关系。
Eye (Lond). 2009 Feb;23(2):453-60. doi: 10.1038/eye.2008.349. Epub 2008 Nov 28.
4
Mechanisms of age-related macular degeneration and therapeutic opportunities.年龄相关性黄斑变性的发病机制及治疗新靶点
J Pathol. 2014 Jan;232(2):151-64. doi: 10.1002/path.4266.
5
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.维替泊芬治疗年龄相关性黄斑变性患者的黄斑中心凹下脉络膜新生血管：关于基线病变组成对视力结果影响的补充信息——TAP报告第3号
Arch Ophthalmol. 2002 Nov;120(11):1443-54. doi: 10.1001/archopht.120.11.1443.
6
Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration: a 12-month follow-up study.玻璃体内注射贝伐单抗治疗特发性黄斑下脉络膜新生血管的 12 个月随访研究
Retina. 2009 Oct;29(9):1227-34. doi: 10.1097/IAE.0b013e3181b773e1.
7
An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.抗血管内皮生长因子治疗多灶性脉络膜炎继发脉络膜新生血管与湿性年龄相关性黄斑变性的疗效分析。
J Zhejiang Univ Sci B. 2018;19(4):327-332. doi: 10.1631/jzus.B1700535.
8
Effects of Huangban Bianxing One decoction combined with ranibizumab on treating exudative age-related macular degeneration.黄斑变性一号方联合雷珠单抗治疗渗出性年龄相关性黄斑变性的疗效
J Tradit Chin Med. 2019 Dec;39(6):892-901.
9
Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.玻璃体内曲安奈德治疗年龄相关性黄斑变性的临床证据。
Curr Drug Targets. 2011 Feb;12(2):149-72. doi: 10.2174/138945011794182746.
10
Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration.阿柏西普治疗延长方案用于厚脉络膜新生血管病变和1型新生血管性年龄相关性黄斑变性的疗效
Jpn J Ophthalmol. 2018 Mar;62(2):144-150. doi: 10.1007/s10384-018-0562-0. Epub 2018 Feb 6.
引用本文的文献
1
Effects of traditional Chinese medicine in the treatment of patients with central serous chorioretinopathy: A systematic review and meta-analysis.中药治疗中心性浆液性脉络膜视网膜病变的疗效：系统评价和荟萃分析。
PLoS One. 2024 Jun 21;19(6):e0304972. doi: 10.1371/journal.pone.0304972. eCollection 2024.
2
Discovering the Potential of Natural Antioxidants in Age-Related Macular Degeneration: A Review.探索天然抗氧化剂在年龄相关性黄斑变性中的潜力：综述
Pharmaceuticals (Basel). 2022 Jan 14;15(1):101. doi: 10.3390/ph15010101.
本文引用的文献
1
Next-generation therapeutic solutions for age-related macular degeneration.针对年龄相关性黄斑变性的新一代治疗方案。
Pharm Pat Anal. 2012 May;1(2):193-206. doi: 10.4155/ppa.12.12.
2
Pollen Typhae is a rapid hemostyptic.蒲黄是一种快速止血剂。
Blood Coagul Fibrinolysis. 2012 Apr;23(3):254-5. doi: 10.1097/MBC.0b013e3283504148.
3
Antibacterial and anti-inflammatory activity of traditional Chinese herb pairs, Angelica sinensis and Sophora flavescens.当归-苦参药对对金黄色葡萄球菌和大肠杆菌的抑菌及抗炎活性
Inflammation. 2012 Jun;35(3):913-9. doi: 10.1007/s10753-011-9393-6.
4
Fritillaria ussuriensis extract inhibits the production of inflammatory cytokine and MAPKs in mast cells.平贝母提取物抑制肥大细胞中炎性细胞因子和丝裂原活化蛋白激酶的产生。
Biosci Biotechnol Biochem. 2011;75(8):1440-5. doi: 10.1271/bbb.110076. Epub 2011 Aug 7.
5
n-Butanol extracts of Panax notoginseng suppress LPS-induced MMP-2 expression in periodontal ligament fibroblasts and inhibit osteoclastogenesis by suppressing MAPK in LPS-activated RAW264.7 cells.三七正丁醇提取物通过抑制 LPS 激活的 RAW264.7 细胞中的 MAPK 抑制牙周膜成纤维细胞中 LPS 诱导的 MMP-2 表达并抑制破骨细胞生成。
Arch Oral Biol. 2011 Nov;56(11):1319-27. doi: 10.1016/j.archoralbio.2011.05.010. Epub 2011 Jun 23.
6
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration.抗淀粉样蛋白治疗可预防年龄相关性黄斑变性模型中的视网膜色素上皮损伤和视力丧失。
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):E279-87. doi: 10.1073/pnas.1100901108. Epub 2011 Jun 20.
7
8
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo.天然化合物丁烯基苯酞来源于当归挥发油，能够抑制血管生成在体外和体内。
Angiogenesis. 2011 May;14(2):187-97. doi: 10.1007/s10456-011-9202-8. Epub 2011 Feb 15.
9
Anti-oxidative effects of the biennial flower of Panax notoginseng against H2O2-induced cytotoxicity in cultured PC12 cells.二年生三七花对 H2O2 诱导的 PC12 细胞毒性的抗氧化作用。
Chin Med. 2010 Oct 28;5:38. doi: 10.1186/1749-8546-5-38.
10
A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.一种改良的东方药物 Jangwonhwan 制剂（LMK03）可降低阿尔茨海默病 Tg-APPswe/PS1dE9 小鼠模型大脑中的 Abeta(1-42)水平。
J Ethnopharmacol. 2010 Aug 9;130(3):578-85. doi: 10.1016/j.jep.2010.05.055.
Zotero 插件